Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT07162883 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07162883
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2026-12-31
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.